Human genetic investigation of TMPRSS6 as a therapeutic target for liver disease: efficacy and safety liabilities
Abstract Background & Aims: Disease-modifying therapies for steatohepatitis and fibrosis remain limited. Matriptase-2 (TMPRSS6), a serine protease suppress